| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FSTX | F-star Therapeutics, Inc. | Bermingham Nessan | Director | Mar 08, 2023 | Option Exercise | $7.12 | 103,875 | 739,590 | 6,328 | Mar 09, 2023, 09:12 AM | |
| NTLA | Intellia Therapeutics, Inc. | Bermingham Nessan | President & CEO | Dec 08, 2017 | Sale | $20.82 | 94,143 | 1,960,151 | 458,250 | Dec 08, 2017, 05:27 PM | |
| NTLA | Intellia Therapeutics, Inc. | Bermingham Nessan | President & CEO | Dec 06, 2017 | Sale | $20.34 | 111,500 | 2,268,001 | 696,000 | Dec 08, 2017, 05:27 PM | |
| NTLA | Intellia Therapeutics, Inc. | Bermingham Nessan | President & CEO | Dec 07, 2017 | Sale | $21.14 | 131,140 | 2,771,867 | 579,959 | Dec 08, 2017, 05:27 PM | |
| NTLA | Intellia Therapeutics, Inc. | Bermingham Nessan | President & CEO | Jun 01, 2017 | Option Exercise | $11.95 | 8,400 | 100,379 | 795,033 | Jun 05, 2017, 07:53 AM |
Menu